Caxton Associates (New York)’s Progyny PGNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-24,010
Closed -$1.23M 704
2022
Q1
$1.23M Buy
24,010
+9,985
+71% +$428K 0.1% 79
2021
Q4
$706K Buy
14,025
+8,235
+142% +$461K 0.07% 186
2021
Q3
$324K Buy
+5,790
New +$320K 0.04% 298
2021
Q2
Sell
-5,062
Closed -$225K 578
2021
Q1
$225K Buy
+5,062
New +$236K 0.02% 354

Other funds holding PGNY

Caxton Associates (New York)'s PGNY Position: Q2 2022 in Review

Caxton Associates (New York) sold out of Progyny (PGNY) in Q2 2022, closing a stake of 24,010 shares — an estimated $1.23M sold.

Caxton Associates (New York) first reported a position in PGNY in Q1 2021 and held it in 4 quarters. The position peaked at $1.23M in Q1 2022. 247 funds tracked by Wall St. Rank hold PGNY as of Q2 2022.

  • Caxton Associates (New York) reported no remaining Progyny position as of Q2 2022 after selling out during the quarter.
  • Caxton Associates (New York) sold 24,010 Progyny shares in Q2 2022, an estimated $1.23M.
  • Caxton Associates (New York) first reported a position in Progyny in Q1 2021 and held it in 4 quarters.
  • Caxton Associates (New York)'s Progyny position peaked at $1.23M in Q1 2022.
  • 247 funds tracked by Wall St. Rank held Progyny as of Q2 2022.

Based on Caxton Associates (New York)'s 13F filing for Q2 2022, filed 15 Aug 2022.